Under construction – not a live service
Sign in
Not yet taking people in FranceNo phase

Interest of a Simulated Procedure Performed on a Printed Model in the Endovascular Treatment of Carotid-sylvian Aneurysms

Key facts

Who runs it
University Hospital, Brest
Where
Brest, FranceSee the site
Trial code
Status
Not yet recruiting
People taking part
40 people, planned
Starts
1 Dec 2026
Expected to end
1 Jun 2029
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Operational Pre-Planning
Record updated
9 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Patient over 18 years old
  • Social security affiliation
  • Patient who signed inform consent form
  • Patient with an unruptured saccular carotid-sylvian aneurysm of more than 4 mm in long axis and less than 20 mm
  • Primary preventive treatment decision validated in CPR
  • Patient having benefited from a 3DRA during a previous arteriography dating from less than 6 months, or whose cerebral arteriography is planned less than 2 weeks before the intervention

Who cannot take part

  • Recanalized or previously treated aneurysm (coils, stent, clip, flow disrupter)
  • Allergy to iodinated contrast agents
  • Kidney failure, GFR < 60ml/min/1.73 m2
  • Platelets < 50 x 10 \^ 9/L
  • Unable or unwilling to come for follow-up appointments
  • Weight > 250kg due to weight limits on the angiographic table
  • Patient with a contraindication to MRI
  • Pregnancy, breastfeeding or planning to become pregnant in the following year
  • Limited life expectancy < 1 year
  • Patient participating in another clinical study or having completed their participation less than 30 days ago
  • Patient under legal protection, Patient under guardianship or curatorship
  • Partially thrombosed aneurysm
  • Partially calcified aneurysm
  • Another aneurysm on the same carrier artery already treated (coils, stent, clip, flow disrupter)
  • Ruptured aneurysm

Where in France

  • Pr Gentric Jean-ChristopheBrest, FranceContact: Jean-Christophe Gentric, PrNo longer taking part

About the trial

What the trial wants to find out

It is now considered that 1% to 2% of the French population has an intracranial aneurysm. The major risk of this malformation is essentially the rupture which will lead in 10% of cases to death immediately, in 30% to 50% death within three weeks and in 30% of cases the patients will present a permanent disability. The management of this pathology represents today a major health challenge. Historically, neurosurgery was the discipline of first choice for the treatment of this pathology. This consists of clipping the aneurysm by a surgical approach to exclude it from the blood circulation and thus avoid its rupture. For many years now, interventional neuroradiology has established itself, through its "minimally invasive" and endovascular approach, as the reference treatment for ruptured and non-ruptured intracranial aneurysms: this is embolization. This so-called minimally invasive technique consists of placing directly into the aneurysm, using micro-catheters that are navigated under radiological control from the femoral artery, turns of plates called "coils" or prostheses called " stent" or "flow-diverter". This technique makes it possible to secure the aneurysm from the inside and thus reduce the risk of rupture. Today, 95% of patients are treated using this innovative technique and limited intraoperative risks. Interventional neuroradiology has constantly known in recent years a set of revolutions and innovations in terms of implantable medical devices (IMD) allowing to treat more and more patients with excellent clinical results. Today, the interventional neuroradiologist, assisted by the radiographer, has a very wide range of IMDs that he can combine with each other depending on the type, location, size and shape of the aneurysm. The role of the manipulator, here, is to work closely with the neuroradiologist so that he has, on the one hand, quality images and on the other hand, that he can count on a precious ally, an expert in IMDs, during embolization procedures. However, the wide choice of medical devices and the complexity of the aneurysms to be treated sometimes make treatment complicated. On the day of the "cold" treatment of the aneurysm (i.e. non-ruptured), the technicality of the catheterization and aneurysm's spatial conformation complicates the deployment of embolization equipment. This then sometimes leads to undesirable events such as intraoperative rupture. The very purpose of this study is to be able, by means of a 3D printer, to print the patient's aneurysm from the segmented 3D images obtained during the initial assessment and thus proceed to a simulation of the embolization procedure. This pre-operative planning (PPO) carried out in real conditions aims to anticipate the possible complications that could be encountered on the same day of treatment.

The 2 groups in the trial

  • PPO +Treatment being tested

    Operational Pre-Planning + intracranial aneurysm embolization treatment

    Treatment: Operational Pre-Planning

  • PPO -No study treatment, for comparison

    Only intracranial aneurysm embolization treatment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of the Interest of a Simulated Procedure Performed on a Printed Model in the Endovascular Treatment of Carotid-sylvian Aneurysms
Record updated
9 June 2026